Background
Bakuchiol (BAK), a meroterpene phenol abundant in the plant Psoralea corylifolia, is an emerging cosmeceutical agent with promising anti‐aging, anti‐inflammatory, and antibacterial properties. The trend for “clean” skincare products and search for anti‐aging retinoid alternatives have poised BAK as a “must‐have” ingredient in skincare.
Aims
Our aim was to review the data for the applications of BAK in dermatology.
Methods
This is a systematic review of PubMed.
Results
Thirty articles matched our search terms [“Bakuchiol” and “Dermatology”] or [“Bakuchiol” and “Skin”] of which one did not meet inclusion criteria, 16 were pre‐clinical studies, seven clinical studies, three commentaries, two narrative reviews, and one report on adverse events. BAK has been mostly studied for its effects on photoaging, acne, and post‐inflammatory hyperpigmentation (PIH), showing beneficial results comparable to those achieved by topical retinoids. While having no structural resemblance to retinoids, BAK can function as a retinol analog, through retinol‐like regulation of gene expression. In in vivo studies, BAK was used alone or in combination with other products resulting in a significant reduction in photodamage, hyperpigmentation, wrinkle scores, and acne severity. Additionally, in vitro studies hinted at its anti‐cancer properties by inhibiting epidermal growth factor induced neoplastic cell transformation. Also, demonstrated potential applications in psoriasis by normalizing keratinocyte activity and in pigmentary disorders through inhibition of melanogenesis. There was one adverse event case reported of contact dermatitis in the literature.
Conclusions
Bakuchiol is a retinol alternative with anti‐aging, antibacterial, and anti‐inflammatory properties. Additional studies are warranted to better understand its applications in dermatology.